Purchase Order W81K0021P0253
Award Date 10/1/21
Potential Completion Date 9/30/26
Potential Value $166K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Irwin, CA 92310, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $40,945.50 firm fixed-price delivery order to Revvity Omics Inc. (doing business as Perkinelmer Genetics) on September 29, 2024, for newborn screening testing services at Brian D. Allgood Army Community Hospital (BDAACH) in South Korea. This task order covers the base performance period from September 29, 2024, through September 28, 2025, and was awarded without a small business set-aside designation. The delivery order is issued under a larger single-award...
- Revvity Omics Inc., operating as Perkinelmer Genetics, received a $4,549.50 firm fixed-price delivery order from the Defense Health Agency for newborn screening testing services at Brian D. Allgood Army Community Hospital in South Korea. This delivery order, awarded on July 1, 2025, with completion scheduled for September 28, 2025, represents a task order issued under Revvity Omics Inc.'s larger Indefinite Delivery Contract valued at $301,668 and awarded to the same facility on September 29,...
- The Defense Health Agency issued a $42,993 delivery order to Revvity Omics Inc. on September 29, 2025, for newborn screening testing services at Brian D. Allgood Army Community Hospital in South Korea, with completion by September 28, 2026. This delivery order is issued under a single-award Indefinite Delivery Contract valued at $301,668 with a base period from September 29, 2024, through September 28, 2025, and four one-year option periods extending through September 28, 2029. Place of...
- This is a firm fixed price purchase order awarded by the Medical Command (MEDCOM) component of the U.S. Department of Defense for $75,810.00 to provide newborn screening testing services. The prime contractor is Revvity Omics Inc., doing business as Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc. The contract is for the delivery of specimen collection cards and performance of clinical laboratory analysis on newborn blood samples to screen for certain congenital metabolic...
- This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn screening services. The contract has a ceiling value of $371,000.00 and a period of performance from October 1, 2021 through September 30, 2024. Perkinelmer Genetics will provide screening of newborns for inherited metabolic disorders and other conditions, as recommended by the American College of Medical Genetics, for military...
- <p>The Defense Health Agency issued a delivery order to the California Department of Public Health on May 1, 2026, for newborn screening services with a ceiling value of $66,896 under firm fixed price terms.</p> <p>Place of performance is Twentynine Palms, CA. The order is scheduled for ultimate completion on April 30, 2027. No set-aside was used.</p>
- Air Forces Europe and Africa issued a purchase order to Revvity Omics Inc. for newborn metabolic screening services at Aviano Air Base, Italy, valued at $60,495 and awarded February 28, 2022. The order carries a firm fixed-price structure with ultimate completion scheduled for February 28, 2027. The requirement covers newborn screening service delivery to the 31st Medical Group at Aviano Air Base. The underlying solicitation was posted February 1, 2022, with a due date of February 8, 2022, and...
- This firm fixed-price purchase order contract was awarded by the Department of the Army Medical Command to Revvity Omics Inc., doing business as Perkinelmer Genetics, for comprehensive newborn screening services. The contract has a potential value of $375,186.00 and a completion date of September 30, 2016. Perkinelmer Genetics, a for-profit subsidiary of Revvity Inc., specializes in medical imaging and genetic testing services. This contract supports the military healthcare system by providing...
- The Defense Health Agency awarded a purchase order to the Department of General Services Virginia on November 6, 2023, for newborn metabolic screening and reporting services at A.T. Augusta Military Medical Center, with a ceiling value of $1,380,000 and an ultimate completion date of November 5, 2028. Performance occurs at Fort Belvoir, Virginia. The order is firm fixed-price with no set-aside designation. Services include newborn blood spot testing, case management for abnormal metabolic...
- The Defense Health Agency awarded a $375,000 firm fixed-price purchase order to the Board of Regents of the Nevada System of Higher Education, operating through the University of Nevada, Reno (UNR), for newborn metabolic screening services. The contract, awarded on September 15, 2025, with an ultimate completion date of September 14, 2030, will be performed in Reno, Nevada. This award does not utilize a set-aside designation, reflecting UNR's competitive standing as a land-grant research...